Vymedic

Early Stage

Scientifically proven broad-spectrum antiviral beats industry-leading treatments in the suppression of flu, colds and common viruses.

Analytics

Raised to Date: Raised: $202,770

Aggregate Commitments $

Platform

Netcapital

Start Date

09/25/2020

Close Date

03/24/2021

Min. Goal

$10,000

Max. Goal

$1,070,000

Min. Investment

$100

Security Type

Equity - Common

Funding Type

RegCF / RegD 506(c)

Series

Pre-Seed

Pre-Money Valuation

$20,000,000

Rolling Commitments $

Status
Funded
Reporting Date

03/31/2021

Days Remaining
Funded
% of Min. Goal

2,028%

% of Max. Goal

19%

Likelihood of Max
Funded
Avg. Daily Raise

$1,127

Momentum
Funded
Log in or create a free account today to gain access to KingsCrowd analytics.
Location

Englewood, Colorado

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2C

Margin

High

Capital Intensity

High

Business Type

Growth

Vymedic, with a post-money valuation of $23 million, is raising crowdfunding on NetCapital. The company has manufactured Vymune, a broad-spectrum antiviral, that beats other treatments in the suppression of influenza. Vymune is not strain-specific and activates the immune system against the illness. Cynthia Winning founded Vymedic in March 2020. The current crowdfunding round has a minimum goal of $10,000 and a maximum goal of $1,070,000, and the proceeds will be used for hiring, manufacturing, and marketing. The product of Vymedic is patented, natural, and made up of amino acids, bioflavonoids, and co-factors. It is safe to use for children, elderly, pregnant women, and immunosuppressed individuals.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-46,788

$-45,688

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$2,032

$3,105

Accounts Receivable

$0

$0

Total Assets

$2,032

$3,105

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Financials as of: 09/25/2020
Log in or create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Staff Picks (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including Merlin ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by Merlin ratings
Company specific Merlin rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Ratings

Analyst Report

Other Deals

Responsum Health on Republic 2021

The company has created free and disease-specific apps to provide support and knowledge to people with chronic conditions. The apps…

Valuation Cap: $4,500,000
Min Investment: $100
Industry: Healthcare & Pharmaceuticals
Raised $52,826 of $1,070,000 max
RegCF

Koning on Republic 2021

The Koning Breast CT creates high-contrast 3D breast images with high spatial resolution and no painful compression. Dr. Ruola Ning…

Valuation Cap: $200,000,000
Min Investment: $100
Industry: Healthcare & Pharmaceuticals
Raised $662,524 of $5,000,000 max
RegCF

SelfDecode on Wefunder 2021

The company has developed an AI-based platform that analyses DNA, labs, and the environment to provide personalized health recommendations. The…

Valuation: $34,948,219
Min Investment: $100
Industry: Healthcare & Pharmaceuticals
Raised $1,085,030 of $1,069,999 max
RegCF

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Vymedic on NetCapital
$
Platform: Netcapital
Security Type: Equity - Common
Valuation: $20,000,000

Follow company

Follow Vymedic on NetCapital